Overview
Januvia 25 mg Tablets contain Sitagliptin, a DPP-4 (dipeptidyl peptidase-4) inhibitor used in the treatment of type 2 diabetes mellitus. It helps improve glycemic control by increasing levels of incretin hormones, which enhance insulin release and decrease glucagon secretion in response to meals. The 25 mg dosage is typically prescribed for patients with severe renal impairment or as advised by a healthcare professional.





